Skip to content
You can now search across every topic, entity and event.What's new
UK Startups and Innovation
21SEP

Clifford quits ARIA chair for Anthropic

2 min read
16:52UTC

Matt Clifford stepped down as chair of the Advanced Research and Invention Agency on 7 September, five days after announcing a move to Anthropic and on the day a Commons committee published its concern.

TechnologyDeveloping
Key takeaway

ARIA lost its chair to a private appointment and has a funding call open without a permanent replacement.

Matt Clifford resigned as chair of the Advanced Research and Invention Agency (ARIA), Britain's high-risk research funder, on 7 September, five days after announcing that he was joining Anthropic as managing director for international affairs 1. He had initially intended to keep the ARIA chair alongside the new role.

Dame Chi Onwurah, who chairs the Commons Science, Innovation and Technology Committee, wrote to government the following week flagging the conflict between chairing a public funder of frontier research and working for a company operating in the field it funds. Clifford stepped down on the day her committee published its comment. Onwurah says she expects a detailed response from government on how the conflict arose and what safeguards protect ARIA's governance.

Chemistry World reports that government asked Clifford to stay on in a transitional capacity until 6 November while a selection process runs 2. ARIA opened the first funding call of its olfactory perception programme on 12 August, one of four programmes that UK Research and Innovation, Innovate UK and ARIA opened between them that month . The agency commits public money into work sitting one step from commercial exploitation, so the identity of the person signing off those commitments carries weight beyond the courtesy of a register entry.

The resolution arrived quickly and by the ordinary route: a select committee named the structural problem, and the appointee left the public post rather than the private one. No finding of wrongdoing attaches to Clifford. What remains open is the process question Onwurah has put to government, which is how a conflict of this shape reached the point of needing a resignation at all.

Deep Analysis

In plain English

Matt Clifford ran the Advanced Research and Invention Agency (ARIA), a British body that funds ambitious scientific research. He quit days after announcing a new job at Anthropic, a US artificial intelligence company, once a House of Commons committee pointed out the conflict between the two roles. ARIA was deliberately designed with fewer of the usual civil service rules, to let it move fast and attract people from outside government. That same design means fewer built-in checks catch a conflict like this before it becomes public.

Deep Analysis
Root Causes

The Advanced Research and Invention Agency Act 2022 gave ARIA deliberately light governance, modelled on DARPA's high-risk, high-reward funding freedom, and exempted its leadership from several standard Civil Service constraints in order to attract figures from outside government.

That same exemption is why a conflict here surfaces through select committee scrutiny rather than a standing pre-appointment ethics check: ARIA's chair role was not built with a DARPA-grade conflicts regime attached to it.

What could happen next?
  • Consequence

    ARIA will need to appoint a new chair while its light-touch governance model faces renewed scrutiny from the same select committee that flagged this conflict.

  • Risk

    Other ARIA leadership figures who hold parallel private-sector roles face the same exposure, since the structural gap Clifford's resignation revealed has not been closed.

First Reported In

Update #15 · Nscale takes $103.4bn of contracts to NYSE

Science, Innovation and Technology Committee· 21 Sept 2026
Read original
Causes and effects
This Event
Clifford quits ARIA chair for Anthropic
Britain's high-risk research funder is running a live funding call without a permanent chair.
Different Perspectives
Nscale and Open Cosmos
Nscale and Open Cosmos
Nscale chose the New York Stock Exchange for its listing on 18 September, putting Britain's largest AI infrastructure bet to American public investors rather than British ones. Open Cosmos took the opposite route four days earlier, raising nine figures from an all-domestic syndicate on five years of profit, evidence that staying is possible when the balance sheet allows it.
Dame Chi Onwurah and the Science, Innovation and Technology Committee
Dame Chi Onwurah and the Science, Innovation and Technology Committee
Committee chair Dame Chi Onwurah wrote to government on 7 September asking how Matt Clifford's conflict at ARIA arose and what safeguards protect its governance, and expects a detailed response. Her question has not yet been put to the Sovereign AI Unit, whose own chair sits at a venture capital firm while overseeing state AI equity.
The Entrepreneurs Network
The Entrepreneurs Network
The Entrepreneurs Network's founder survey found 65% say Britain is easy to start a business in but only 14% say it is easy to scale one, with 82% negative on tax and 74% finding investment hard to access. On this reading the constraint is regulation and tax, not the capital-vehicle design the state keeps adjusting.
New Economics Foundation
New Economics Foundation
The New Economics Foundation argues fiscal accounting rules, not political will, cap what Britain's state capital vehicles can do. Matching the KfW and Bpifrance benchmark of 1% of GDP would need the National Wealth Fund to deploy roughly GBP21bn a year by 2028-29, about four times its current capacity.
Competition and Markets Authority
Competition and Markets Authority
The CMA's 8 September report on public procurement asked whether Britain's roughly GBP400bn state-spending system is built to grow high-potential firms rather than simply widen SME participation. Its Recommendation 5 calls for a dedicated frontier-technology procurement framework, an official acknowledgement that today's design may serve the wrong target.
Highland Europe
Highland Europe
Highland Europe, the growth-equity firm behind a €1bn-plus fund, took €65m from the British Business Bank into its Technology Growth Fund VI on 30 July via British Patient Capital. For a Geneva-based growth investor, the Bank's cheque is routine cornerstone capital, unrelated to which Whitehall department currently claims to sponsor UKRI.